Dry Eye Disease: Emerging Therapies

Dry eye disease (DED) is evolving with promising therapies aimed at alleviating symptoms and improving ocular surface health. Emerging treatments include novel lubricants, such as lipid-based formulations, which stabilize tear film and enhance moisture retention. Anti-inflammatory agents target underlying immune responses that contribute to chronic dryness and discomfort. Advanced technologies like intense pulsed light therapy and thermal pulsation systems offer non-invasive approaches to improve Meibomian gland function and alleviate evaporative dry eye. Furthermore, regenerative therapies utilizing growth factors and stem cells show potential for restoring damaged ocular tissues and promoting natural tear production. These innovations signal a hopeful future for managing DED more effectively and enhancing patients' quality of life.

    Related Conference of Dry Eye Disease: Emerging Therapies

    April 07-08, 2025

    6th World congress on Ophthalmology and Optometry

    Amsterdam, Netherlands
    April 29-30, 2025

    35th International Congress on Vision Science and Eye

    Barcelona, Spain
    April 29-30, 2025

    6th World Congress on Ophthalmology and Vision Science

    Barcelona, Spain
    June 12-13, 2025

    6th International Conference on Optometry

    London, UK
    June 17-18, 2025

    25th Global Ophthalmologists Annual Meeting

    Copenhagen, Denmark
    September 16-17, 2025

    20th International Conference on Ophthalmology and Vision Science

    Amsterdam, Netherlands
    September 22-23, 2025

    8th International Eye and Vision Congress

    Amsterdam, Netherlands

    Dry Eye Disease: Emerging Therapies Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in